Personalities affiliated to the Swiss startup ecosystem are among Forbes “30under30” Europe 2017. They include startup founders of: Depsys, Wingtra, CellSpring, chronext and GovFaces, and Opthorobotics, an investor and a supporter. The nominated individuals are all united by one feature: the hunger for innovation in their respective fields.
Technology Fund announces that it closed 2016 successfully with 26 loan Guarantees granted to startups and SMEs developing technologies for the reduction of greenhouse emissions. The organisation will continue to focus its efforts and energy on making 2017 a success too.
Malin Corporation plc, an Irish-based and globally operating life sciences company, announced that it has acquired an 80 percent shareholding of Cilatus BioPharma AG. Cilatus specialises in strategic and operational consulting services for small, medium and large biopharma Companies.
Venturelab is organising the next startup development programs for hightech startups to China and life sciences to Boston. 10 selected startups from each category will have the opportunity to explore the foreign market while expanding their business and personal networks. Registration is open.
The Lausanne based startup Teleport offers a SaaS platform that enables users to create interactive videos. Two months ago, the startup was selected to participate in the American accelerator “500 startups”. Gavrilo Bozovic, CEO of Teleport, shares his experience and achievements in this interview.
Enterprises in Switzerland devoted more than CHF 15.7 billion to their research and development activities (R&D) in 2015. At international level, Switzerland is among those countries where enterprises are the most active in R&D. These are some of the main findings from the survey conducted by the Federal Statistical Office (FSO) in partnership with economiesuisse.
Im heute erschienenen Bericht betont der Bundesrat die Chancen der digitalen Wirtschaft. Neue Gesetze brauche es nicht. Im Bereich der Forschung und Entwicklung soll geprüft werden, welche zusätzlichen Forschungskapazitäten es braucht.